Sumito Shingaki

461 total citations
15 papers, 134 citations indexed

About

Sumito Shingaki is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Sumito Shingaki has authored 15 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Sumito Shingaki's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Acute Myeloid Leukemia Research (2 papers). Sumito Shingaki is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers) and Acute Myeloid Leukemia Research (2 papers). Sumito Shingaki collaborates with scholars based in Japan, United Kingdom and Sweden. Sumito Shingaki's co-authors include Mariko Tabata, Kenshi Suzuki, Kota Yoshifuji, Yasunori Kogure, Marni B. McClure, Yuki Saito, Takanori Kanai∥, Yasushi Okuno, Shigeyuki Matsumoto and Keisuke Kataoka and has published in prestigious journals such as Nature, Blood and Leukemia.

In The Last Decade

Sumito Shingaki

13 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumito Shingaki Japan	4	87	35	33	24	23	15	134
Andrej Lissat Germany	7	94 1.1×	43 1.2×	26 0.8×	55 2.3×	19 0.8×	17	181
Dias Kurmashev United States	7	116 1.3×	52 1.5×	17 0.5×	35 1.5×	10 0.4×	10	162
Brandon Blue United States	6	72 0.8×	68 1.9×	46 1.4×	11 0.5×	79 3.4×	27	163
Cunjian Yi China	9	84 1.0×	44 1.3×	66 2.0×	21 0.9×	10 0.4×	26	194
Eva Zebedin-Brandl Austria	8	89 1.0×	134 3.8×	26 0.8×	24 1.0×	25 1.1×	18	267
Zachary Crees United States	9	98 1.1×	69 2.0×	14 0.4×	15 0.6×	31 1.3×	34	199
Alexander Murison United Kingdom	5	151 1.7×	38 1.1×	55 1.7×	74 3.1×	64 2.8×	13	223
Kyle Ferchen United States	5	148 1.7×	30 0.9×	38 1.2×	17 0.7×	79 3.4×	9	237
Tressa Hood United States	8	37 0.4×	71 2.0×	43 1.3×	32 1.3×	24 1.0×	20	133

Countries citing papers authored by Sumito Shingaki

Since Specialization

Citations

This map shows the geographic impact of Sumito Shingaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumito Shingaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumito Shingaki more than expected).

Fields of papers citing papers by Sumito Shingaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumito Shingaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumito Shingaki. The network helps show where Sumito Shingaki may publish in the future.

Co-authorship network of co-authors of Sumito Shingaki

This figure shows the co-authorship network connecting the top 25 collaborators of Sumito Shingaki. A scholar is included among the top collaborators of Sumito Shingaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumito Shingaki. Sumito Shingaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Yoshifuji, Kota, Yuki Saito, Mariko Tabata, et al.. (2025). In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis. Blood Advances. 9(19). 5040–5055.

Shingaki, Sumito, Junji Koya, Mitsuhiro Yuasa, et al.. (2022). Tumor-promoting function and regulatory landscape of PD-L2 in B-cell lymphoma. Leukemia. 37(2). 492–496. 1 indexed citations

Saito, Yuki, Junji Koya, Mitsugu Araki, et al.. (2020). Landscape and function of multiple mutations within individual oncogenes. Nature. 582(7810). 95–99. 84 indexed citations

Shingaki, Sumito, Takahiro Kogawa, Mototsugu Shimokawa, et al.. (2020). Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer. Journal of Cancer. 11(14). 4099–4105. 3 indexed citations

Saito, Yuki, Takuro Kameda, Yasunori Kogure, et al.. (2020). Dissecting Multicellular Ecosystems of HTLV-1 Infection and ATL By Multi-Omics Single Cell Analysis. Blood. 136(Supplement 1). 18–18.

Shingaki, Sumito, N Tsukada, Masahiro Ikeda, & Kenshi Suzuki. (2018). Graft-versus-host Disease–free, Relapse-free Survival After HLA-identical Sibling Peripheral Blood Stem Cell Transplantation With Tacrolimus-based Graft-versus-host Disease Prophylaxis in Japanese Patients. Transplantation Proceedings. 50(1). 241–245. 1 indexed citations

Ishida, Tadao, Masahiro Ikeda, Sumito Shingaki, et al.. (2018). [IgE-κ type multiple myeloma achieving complete response with novel agents].. PubMed. 58(11). 2232–2237. 1 indexed citations

Ikeda, Masahiro, et al.. (2017). Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy.. PubMed. 58(3). 216–221. 8 indexed citations

Shingaki, Sumito, Masatoshi Hotta, Makoto Kobayashi, et al.. (2016). Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis. International Journal of Hematology. 105(3). 295–308. 23 indexed citations

10.

Tsukada, Nobuhiro, Masahiro Ikeda, Sumito Shingaki, et al.. (2015). High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases. International Journal of Hematology. 103(3). 299–305. 5 indexed citations

11.

Tsukada, Nobuhiro, Masahiro Ikeda, Sumito Shingaki, et al.. (2015). [Induction treatment with bortezomib-cyclophosphamide-dexamethasone (CyBorD) for newly diagnosed transplant-eligible patients with multiple myeloma].. PubMed. 56(8). 1069–75. 2 indexed citations

12.

Tsukada, Nobuhiro, Sumito Shingaki, Masahiro Ikeda, et al.. (2015). [Graft-versus-host disease associated with lenalidomide maintenance after allogeneic transplantation for relapsed/refractory multiple myeloma].. PubMed. 56(7). 895–900. 1 indexed citations

13.

Inoue, Junko, Masahiro Ikeda, Sumito Shingaki, et al.. (2015). [The clinical significance of decrease in CD138 positive cell ratio in multiple myeloma].. PubMed. 56(11). 2311–7. 2 indexed citations

14.

Shingaki, Sumito, Yu Abe, Yasunori Nakagawa, et al.. (2014). Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia.. PubMed. 55(4). 428–35. 2 indexed citations

15.

Shingaki, Sumito, et al.. (1980). Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions.. PubMed. 38(12). 886–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact